Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06617013
NA

GERD in Children With Cystic Fibrosis

Sponsor: Duke University

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the prevalence of gastroesophageal reflux disease (GERD) symptoms in pediatric patients with cystic fibrosis using the Gastroesophageal Symptom Assessment Scale (GSAS) and the impact of stopping anti-GERD therapy on the GERD symptoms reported.

Official title: Characteristics of Gastroesophageal Reflux in Children With Cystic Fibrosis

Key Details

Gender

All

Age Range

2 Years - 18 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2024-10-23

Completion Date

2026-06-30

Last Updated

2025-12-19

Healthy Volunteers

No

Interventions

OTHER

Discontinuation of GERD therapy

GERD therapy will be discontinued at time of enrollment.

Locations (1)

Duke University Hospital

Durham, North Carolina, United States